Oriola serves the Finnish and Swedish markets with a wide services portfolio. The company offers advanced distribution, expert and advisory services for pharmaceutical companies and a wide range of health and wellbeing products for pharmacies, veterinarians, other healthcare operators and retail operators. Additionally, Oriola offers dose dispensing services for pharmacies and healthcare operators.
In Sweden, Oriola also provides products and services for health and wellbeing for consumer customers through Kronans Apotek, the third largest pharmacy chain in Sweden with a strong focus on growing online business. In February 2022, Oriola and Euroapotheca announced a framework agreement for combining their respective pharmacy businesses in Sweden. The planned merger is subject to competition authorities’ approval.
From the beginning of 2022, Oriola has operated in a new operating model. As of the beginning of the 2022, Oriola reports continuing operations including all B2B operations in Finland and Sweden as a new reportable segment: Oriola Services.
Due to the planned merger of the pharmacy business in Sweden, Consumer segment is classified as discontinued operations in financial reporting as of the Q1 Interim Report.